参考文献/References:
[1]Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.[2]Gori S,Inno A,Belluomini L,et al.Gut microbiota and cancer: how gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy[J].Crit Rev Oncol Hematol,2019,143:139-147.[3]Goubet AG,Daillère R,Routy B,et al.The impact of the intestinal microbiota in therapeutic responses against cancer[J].CR Biol,2018,341(5):284-289.[4]Pitt JM,Vétizou M,Gomperts Boneca I,et al.Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota[J].Oncoimmunology,2017,6(1):e1132137.[5]Blumberg R,Powrie F.Microbiota, disease, and back to health: a metastable journey[J].Sci Transl Med,2012,4(137):137rv7.[6]Thursby E,Juge N.Introduction to the human gut microbiota[J].Biochem J,2017,474(11):1823-1836.[7]Tanoue T,Morita S,Plichta DR,et al.A defined commensal consortium elicits CD8 T cells and anti-cancer immunity[J].Nature,2019,565(7741):600-605.[8]Li J,Sung CY,Lee N,et al.Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice[J].Proc Natl Acad Sci U S A,2016,113(9):E1306-E1315.[9]Thaiss CA,Levy M,Itav S,et al.Integration of innate immune signaling[J].Trends Immunol,2016,37(2):84-101.[10]Brown EM,Kenny DJ,Xavier RJ.Gut microbiota regulation of T cells during inflammation and autoimmunity[J].AnnuRevImmunol,2019,37:599-624.[11]Gharaibeh RZ,Jobin C.Microbiota and cancer immunotherapy: in search of microbial signals[J].Gut,2019,68(3):385-388.[12]Zhuo Q,Yu BH,Zhou J,et al.Lysates of Lactobacillus acidophilus combined with CTLA-4-blocking antibodies enhance antitumor immunity in a mouse colon cancer model[J].Sci Rep,2019,9(1):20128.[13]Chaput N,Lepage P,Coutzac C,et al.Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab[J].Ann Oncol,2019,30(12):2012.[14]Fuentes-Antrás J,Provencio M,Díaz-Rubio E.Hyperprogression as a distinct outcome after immunotherapy[J].Cancer Treat Rev,2018,70:16-21.[15]Saada-Bouzid E,Defaucheux C,Karabajakian A,et al.Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma[J].Ann Oncol,2017,28(7):1605-1611.[16]Santoni M,Piva F,Conti A,et al.Re:gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors[J].Eur Urol,2018,74(4):521-522.[17]Matson V,Fessler J,Bao RY,et al.The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients[J].Science,2018,359(6371):104-108.[18]Gopalakrishnan V,Spencer CN,Nezi L,et al.Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients[J].Science,2018,359(6371):97-103.[19]Dubin K,Callahan MK,Ren BY,et al.Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis[J].Nat Commun,2016,7:10391.[20]Vétizou M,Pitt JM,Daillère R,et al.Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota[J].Science,2015,350(6264):1079-1084.[21]Forslund K,Sunagawa S,Coelho LP,et al.Metagenomic insights into the human gut resistome and the forces that shape it[J].Bioessays,2014,36(3):316-329.[22]Singh S,Verma N,Taneja N.The human gut resistome: current concepts & future prospects[J].Indian J Med Res,2019,150(4):345-358.[23]Li J,Rettedal EA,van der Helm E,et al.Antibiotic treatment drives the diversification of the human gut resistome[J].Genomics Proteomics Bioinformatics,2019,17(1):39-51.[24]Derosa L,Hellmann MD,Spaziano M,et al.Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer[J].Ann Oncol,2018,29(6):1437-1444.[25]Lee KA,Luong MK,Shaw H,et al.The gut microbiome: what the oncologist ought to know[J].BrJ Cancer,2021,125(9):1197-1209.[26]Wang F,Yin Q,Chen L,et al.Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade[J].Proc Natl Acad Sci U S A,2018,115(1):157-161.[27]Pierrard J,Seront E.Impact of the gut microbiome on immune checkpoint inhibitor efficacy-a systematic review[J].Curr Oncol,2019,26(6):395-403.[28]Pinato DJ,Howlett S,Ottaviani D,et al.Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer[J].JAMA Oncol,2019,5(12):1774-1778.[29]Ooijevaar RE,van Beurden YH,Terveer EM,et al.Update of treatment algorithms for Clostridium difficile infection[J].Clin Microbiol Infect,2018,24(5):452-462.[30]Czepiel J,Drózdz M,Pituch H,et al.Clostridium difficile infection:review[J].Eur J Clin Microbiol Infect Dis,2019,38(7):1211-1221.[31]Mathew S,Barton J,Ong AW.Duodenal infusion of donor feces for recurrent clostridium difficile. 50 Landmark Papers[J].Boca:CRC Press,2019:91-92.[32]Tariq R,Pardi DS,Bartlett MG,et al.Low cure rates in controlled trials of fecal microbiota transplantation for recurrent clostridium difficile infection: a systematic review and meta-analysis[J].Clin Infect Dis,2019,68(8):1351-1358.[33]Schwan A,Sj?觟lin S,Trottestam U,et al.Relapsing clostridium difficile enterocolitis cured by rectal infusion of homologous faeces[J].Lancet,1983,2(8354):845.[34]Paramsothy S,Kamm MA,Kaakoush NO,et al.Multidonor intensive faecal microbiota transplantation for active ulcerative colitis:a randomised placebo-controlled trial[J].Lancet,2017,389(10075):1218-1228.[35]Zheng Y,Wang TT,Tu XX,et al.Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma[J].J Immunother Cancer,2019,7(1):193.[36]Toscano M,de Grandi R,Stronati L,et al.Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: a preliminary study[J].World J Gastroenterol,2017,23(15):2696-2704.[37]Koh A,B?ckhed F.From association to causality: the role of the gut microbiota and its functional products on host metabolism[J].Mol Cell,2020,78(4):584-596.[38]Wang YH,Wiesnoski DH,Helmink BA,et al.Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis[J].Nat Med,2018,24(12):1804-1808.[39]Zhao Q, Elson CO.Adaptive immune education by gut microbiota antigens[J].Immunology,2018,154(1):28-37.[40]Shogbesan O,Poudel DR,Victor S,et al.A systematic review of the efficacy and safety of fecal microbiota transplant for clostridium difficile infection in immunocompromised patients[J].Can J Gastroenterol Hepatol,2018,2018:1394379.[41]Taur Y,Coyte K,Schluter J,et al.Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant[J].Sci Transl Med,2018,10(460):eaap9489.[42]Ka?mierczak-Siedlecka K,Daca A,Fic M,et al.Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics[J].Gut Microbes,2020,11(6):1518-1530.[43]Hendler R,Zhang Y.Probiotics in the treatment of colorectal cancer[J].Medicines (Basel),2018,5(3):E101.[44]Gu ZL,Wu YF,Wang Y,et al.Lactobacillus rhamnosus granules dose-dependently balance intestinal microbiome disorders and ameliorate chronic alcohol-induced liver injury[J].J Med Food,2020,23(2):114-124.[45]张宝元,马晓红,刘震,等.双歧杆菌及其WPG对S180荷瘤小鼠免疫调节和抑瘤作用研究[J].中国微生态学杂志,2001,13(1):8-10.[46]Sivan A,Corrales L,Hubert N,et al.Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy[J].Science,2015,350(6264):1084-1089.[47]Frankel AE,Coughlin LA,Kim J,et al.Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients[J].Neoplasia,2017,19(10):848-855.[48]Suez J,Zmora N,Zilberman-Schapira G,et al.Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT[J].Cell,2018,174(6):1406-1423.[49]Zmora N,Zilberman-Schapira G,Suez J,et al.Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features[J].Cell,2018,174(6):1388-1405.[50]Wan MLY,Forsythe SJ,El-Nezami H.Probiotics interaction with foodborne pathogens: a potential alternative to antibiotics and future challenges[J].Crit Rev Food Sci Nutr,2019,59(20):3320-3333.[51]Tannock GW,Munro K,Harmsen HJ,et al.Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosusDR20[J].Appl Environ Microbiol,2000,66(6):2578-2588.[52]Valcheva R,Dieleman LA.Prebiotics: Definition and protective mechanisms[J].Best Pract Res Clin Gastroenterol,2016,30(1):27-37.[53]Ruiz-Ojeda FJ,Plaza-Díaz J,Sáez-Lara MJ,et al.Effects of sweeteners on the gut microbiota: a review of experimental studies and clinical trials[J].Adv Nutr,2019,10(suppl_1):S31-S48.[54]Markowiak P,Slizewska K.Effects of probiotics, prebiotics, and synbiotics on human health[J].Nutrients,2017,9(9):1021.[55]Nie Y,Lin QL,Luo FJ.Effects of non-starch polysaccharides on inflammatory bowel disease[J].Int J Mol Sci,2017,18(7):1372.[56]Wang SM,Xiao Y,Tian FW,et al.Rational use of prebiotics for gut microbiota alterations: specific bacterial phylotypes and related mechanisms[J].J Funct Foods,2020,66:103838.[57]Vandeputte D,Falony G,Vieira-Silva S,et al.Prebiotic inulin-type fructans induce specific changes in the human gut microbiota[J].Gut,2017,66(11):1968-1974.[58]Hughes RL,Alvarado DA,Swanson KS,et al.The prebiotic potential of inulin-type fructans: asystematic review[J].AdvNutr,2021:nmab119.[59]Russell JT,Roesch LFW,?魻rdberg M,et al.Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome[J].Nat Commun,2019,10:3621.[60]Wilson AS,Koller KR,Ramaboli MC,et al.Diet and the human gut microbiome: an international review[J].Dig Dis Sci,2020,65(3):723-740.[61]Rothschild D,Weissbrod O,Barkan E,et al.Environment dominates over host genetics in shaping human gut microbiota[J].Nature,2018,555(7695):210-215.[62]Liu L,Tabung FK,Zhang XH,et al.Diets that promote colon inflammation associate with risk of colorectal carcinomas that contain fusobacterium nucleatum[J].Clin Gastroenterol Hepatol,2018,16(10):1622-1631.e3.[63]Mehta RS,Nishihara R,Cao Y,et al.Association of dietary patterns with risk of colorectal cancer subtypes classified by fusobacterium nucleatum in tumor tissue[J].JAMA Oncol,2017,3(7):921-927.[64]Tao J,Li S,Gan RY,et al.Targeting gut microbiota with dietary components on cancer: effects and potential mechanisms of action[J].Crit Rev Food Sci Nutr,2020,60(6):1025-1037.[65]Wilson AS,Koller KR,Ramaboli MC,et al.Diet and the human gut microbiome: an international review[J].Dig Dis Sci,2020,65(3):723-740.[66]Ocvirk S,Wilson AS,Appolonia CN,et al.Fiber,fat,and colorectal cancer: new insight into modifiable dietary risk factors[J].Curr Gastroenterol Rep,2019,21(11):62.[67]Rajilic-Stojanovic M,Jonkers D M,Salonen A,et al.Intestinal microbiota and diet in IBS:causes, consequences, or epiphenomena?[J].The American Journal of Gastroenterology,2015,110(2):278.[68]Sheflin AM,Melby CL,Carbonero F,et al.Linking dietary patterns with gut microbial composition and function[J].Gut Microbes,2017,8(2):113-129.[69]Zhernakova A,Kurilshikov A,Bonder MJ,et al.Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity[J].Science,2016,352(6285):565-569.[70]Ramirez-Farias C,Slezak K,Fuller Z,et al.Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii[J].Br J Nutr,2009,101(4):541-550.[71]Verhoog S,Taneri PE,Roa Díaz ZM,et al.Dietary factors and modulation of bacteria strains of Akkermansia muciniphila and Faecalibacterium prausnitzii:a systematic review[J].Nutrients,2019,11(7):E1565.[72]Valdes AM,Walter J,Segal E,et al.Role of the gut microbiota in nutrition and health[J].BMJ,2018,361:k2179.[73]Hills RDJr,Pontefract BA,Mishcon HR,et al.Gut microbiome: profound implications for diet and disease[J].Nutrients,2019,11(7):E1613.
相似文献/References:
[1]向姣姣,李国娟,杨通艳,等.肠道菌群与肥胖发病机制的研究[J].医学信息,2022,35(10):70.[doi:10.3969/j.issn.1006-1959.2022.10.017]
XIANG Jiao-jiao,LI Guo-juan,YANG Tong-yan,et al.Study on Intestinal Flora and Pathogenesis of Obesity[J].Medical Information,2022,35(11):70.[doi:10.3969/j.issn.1006-1959.2022.10.017]
[2]冯贺强,张彩红.肠道菌群与非酒精性脂肪肝关系的研究进展[J].医学信息,2018,31(12):47.[doi:10.3969/j.issn.1006-1959.2018.12.015]
FENG He-qiang,ZHANG Cai-hong.Research Progress on the Relationship between Intestinal Flora and Nonalcoholic Fatty Liver[J].Medical Information,2018,31(11):47.[doi:10.3969/j.issn.1006-1959.2018.12.015]
[3]姜海燕.双歧杆菌四联活菌治疗对肝硬化患者肝功能、细胞因子及肠道菌群的影响[J].医学信息,2022,35(12):156.[doi:10.3969/j.issn.1006-1959.2022.12.038]
JIANG Hai-yan.Effect of Quadruple Viable Bifidobacterium Treatment on Liver Function, Cytokines and Intestinal Flora in Patients with Liver Cirrhosis[J].Medical Information,2022,35(11):156.[doi:10.3969/j.issn.1006-1959.2022.12.038]
[4]刘丽娟,郭紫薇,陈晶泽,等.电子烟烟雾气体染毒对C57BL/6小鼠肠道菌群的影响[J].医学信息,2020,33(06):72.[doi:10.3969/j.issn.1006-1959.2020.06.021]
LIU Li-juan,GUO Zi-wei,CHEN Jing-ze,et al.Effect of E-cigarette Smoke Gas Exposure on Intestinal Flora of C57BL/6 Mice[J].Medical Information,2020,33(11):72.[doi:10.3969/j.issn.1006-1959.2020.06.021]
[5]俞 帆,李旻倩,沈 芸,等.粪菌移植治疗肠易激综合征的研究[J].医学信息,2021,34(02):50.[doi:10.3969/j.issn.1006-1959.2021.02.014]
YU Fan,LI Min-qian,SHEN Yun,et al.Study of Fecal Bacteria Transplantation for Irritable Bowel Syndrome[J].Medical Information,2021,34(11):50.[doi:10.3969/j.issn.1006-1959.2021.02.014]
[6]王 军.中医药调控肠道菌群治疗重症急性胰腺炎的研究[J].医学信息,2021,34(03):52.[doi:10.3969/j.issn.1006-1959.2021.03.016]
WANG Jun.Study on Treatment of Severe Acute Pancreatitis by Regulating Intestinal Flora with Traditional Chinese Medicine[J].Medical Information,2021,34(11):52.[doi:10.3969/j.issn.1006-1959.2021.03.016]
[7]薛澳徽,热依沙·帕孜力江,陈文婷,等.巨单胞菌属和巴恩斯氏菌属与疾病相关性研究[J].医学信息,2023,36(01):169.[doi:10.3969/j.issn.1006-1959.2023.01.037]
XUE Ao-hui,Reyisha Pazilijiang,CHEN Wen-ting,et al.Study on the Correlation Between Megamonas spp.and Barnesiella spp. and Disease[J].Medical Information,2023,36(11):169.[doi:10.3969/j.issn.1006-1959.2023.01.037]
[8]韦潋滟,徐冬娟.肠道微生物与缺血性脑卒中的相关性研究[J].医学信息,2021,34(11):40.[doi:10.3969/j.issn.1006-1959.2021.11.012]
WEI Lian-yan,XU Dong-juan.Study on the Correlation Between Intestinal Microbes and Ischemic Stroke[J].Medical Information,2021,34(11):40.[doi:10.3969/j.issn.1006-1959.2021.11.012]
[9]王 莹,李钦锋.特应性皮炎与肠道及皮肤菌群的相关性研究[J].医学信息,2021,34(14):54.[doi:10.3969/j.issn.1006-1959.2021.14.015]
WANG Ying,LI Qin-feng.Study on the Correlation Between Atopic Dermatitis and Intestinal and Skin Flora[J].Medical Information,2021,34(11):54.[doi:10.3969/j.issn.1006-1959.2021.14.015]
[10]周 瑞,张雪芬,张 宁,等.抗生素对早产儿肠道菌群影响的研究[J].医学信息,2023,36(03):177.[doi:10.3969/j.issn.1006-1959.2023.03.039]
ZHOU Rui,ZHANG Xue-fen,ZHANG Ning,et al.Effect of Antibiotics on Intestinal Microflora in Premature Infants[J].Medical Information,2023,36(11):177.[doi:10.3969/j.issn.1006-1959.2023.03.039]